At a Glance
F-Prime Capital (fka Fidelity Biosciences) is a venture capital firm based in Boston, MA founded in 2013. F-Prime Capital is a global venture capital firm investing in life sciences, technology healthtech + services, and crypto, with a heritage that spans four decades. The firm focuses on Pre-Seed, Seed, Series A, Series B+ investments across sectors including Aerospace & Defense, Digital Health, Other, Consumer, Fintech. The firm manages $1.8B in assets under management. Notable portfolio companies include Veracyte, Moderna, Flatiron Health, Syapse, Karius, Roivant Sciences and Concerto HealthAI. Invests in healthcare and technology companies at the intersection of biology and technology, focusing on improving human health and transforming industries.
“Invests in healthcare and technology companies at the intersection of biology and technology, focusing on improving human health and transforming industries.”
F-Prime Capital (fka Fidelity Biosciences) primarily invests at the Pre-Seed, Seed, Series A, Series B+ stages. This means they focus on companies that are at the earliest idea or prototype phase.
F-Prime Capital (fka Fidelity Biosciences) is headquartered in Boston, MA. Many of their portfolio companies are also based in this region, though they invest across geographies.
F-Prime Capital (fka Fidelity Biosciences) focuses on investments in Aerospace & Defense, Digital Health, Other, Consumer, Fintech. Their portfolio reflects deep expertise and networks within these sectors.
F-Prime Capital (fka Fidelity Biosciences)'s typical investment check size ranges from $100K to $10M. Actual amounts may vary based on the stage, sector, and specific opportunity.
F-Prime Capital (fka Fidelity Biosciences) manages approximately $1.8B in assets under management (AUM) across their funds.
